When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising ...

Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

On June 23, 2026, the M/T “Pyxis Karteria” safely transited the Strait of Hormuz. Throughout the regional disruption, the vessel remained employed under her existing fixed-rate time charter and ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models. The consensus rating for Pyxis Oncology is "Strong Buy" ...

Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund 78.71k Jun 30, 2026 0.09% 289,649 Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund 26k Jun 30, 2026 0.03% 95,668 ...

As of 12:37:07 PM EDT. Market Open.

Trading Activity price-reliability indicator with 45 percent data coverage. Low activity replaces price-derived sentiment because the displayed market price may not be supported by meaningful trading.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved ...